• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and breastfeeding is a difficult decision for women suffering from the condition. Little data exists about how long-term exposure to these drugs may affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus do not develop neurological disorders like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications must weigh the advantages of using them against the risks to the fetus. Doctors don't have enough data to make unambiguous recommendations however they can provide information about risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not have a significantly increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a massive population-based study of case control to compare the incidence of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists and pediatric cardiologists examined the cases to ensure accurate case classification and to minimize the possibility of bias.

The study of the researchers was not without limitations. Most important, they were unable to distinguish the effects of the medication from those of the underlying disorder. This makes it difficult for researchers to determine whether the few associations observed between the groups that were exposed to the use of medication, or if they were caused by comorbidities. In addition, the researchers did not look at the long-term effects of offspring on their parents.

The study did show that babies whose mothers had taken ADHD medications during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or taken off their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not affected by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an elevated chance of having a caesarean delivery or having a child with an low Apgar score (less than 7). These increases appear to be independent of the type of medication taken during pregnancy.

Researchers suggest that the small risk of using ADHD medication during pregnancies in the early stages could be offset by the greater benefits to both mother and baby from continuing treatment for the woman’s disorder. Physicians should discuss this with their patients and, where they are able, assist them in developing strategies to improve coping skills that may minimize the impact of her disorder on her daily life and relationships.

Interactions with Medication

Doctors are increasingly confronted with the dilemma of whether to continue treatment or stop during pregnancy as more women are diagnosed with ADHD. Most of the time, these decisions are taken in the absence of any evidence that is clear and definitive either way, so physicians must weigh what they know about their experiences, the experiences of other doctors, and what the research suggests about the subject as well as their best adhd medication For adults uk judgment for each patient.

In particular, the issue of possible risks to the baby can be a challenge. The research that has been conducted on this topic is based on observation instead of controlled studies and many of the findings are in conflict. In addition, most studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could result in abortion or termination of the pregnancy. The study that is discussed in the journal club addresses these shortcomings, by examining both the data from deceased and live births.

Conclusion: While some studies have found an association between ADHD medications and certain birth defects however, other studies haven't shown such a relationship. Most studies have shown a neutral, or even slight negative impact. In the end an accurate risk-benefit analysis is required in every instance.

It can be challenging, if not impossible, for women with ADHD to stop taking their medication. In an article recently published in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of isolation, and family conflict for those suffering from the disorder. A loss of medication may also impact the ability to safely drive and perform work-related tasks, which are crucial aspects of everyday life for those suffering from ADHD.

She suggests that women who are not sure whether to continue taking the medication or stop it due to their pregnancy should educate family members, coworkers, and their friends about the condition, the impact on daily functioning and the benefits of continuing the current treatment. It can also make the woman feel more comfortable in her struggle with her decision. Certain medications can pass through the placenta. If the patient decides to stop taking her ADHD medication while breastfeeding, it is crucial to be aware that the drug could be passed on to her baby.

Birth Defects and Risk of

As the use of strattera adhd medication drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns about the effects that the medications could have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Using two massive data sets researchers were able to analyze more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists discovered that the first-trimester exposure to ADHD medications was linked to an increased risk of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study found no link between the use of early medications and other congenital abnormalities, like facial clefting, or club foot. The results are in line with previous studies which showed an insignificant, but small increase in cardiac malformations for women who began taking adhd treatment medication medication prior to the time of pregnancy. The risk was higher during the latter part of pregnancy, when a lot of women decide to stop taking their ADHD medication.

Women who took ADHD best medication for anxiety depression and adhd in the first trimester were more likely need a caesarean and also have a low Apgar after delivery, and have a baby that needed help breathing when they were born. The authors of the study could not remove bias in selection since they restricted the study to women with no other medical conditions that might have contributed to the findings.

The researchers hope that their research will help inform the clinical decisions of physicians who treat pregnant women. The researchers recommend that, while discussing the risks and benefits are important, the decision regarding whether or not to stop taking medication should be in light of the severity of each woman's ADHD symptoms and her needs.

The authors warn that, even though stopping the medication is a possibility to look into, it is not recommended due to the high rate depression and other mental problems for women who are pregnant or have recently given birth. Additionally, the research suggests that women who decide to stop taking their medications are more likely to have difficulties adjusting to life without them following the baby's arrival.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women with ADHD who have to deal with their symptoms while attending physician appointments as well as preparing for the arrival of their child and adjusting to new adhd medication uk household routines can experience severe challenges. Many women choose to continue taking their ADHD medication during pregnancy.

The risk to a nursing infant is low because the majority of stimulant medication is absorbed through breast milk at low levels. However, the frequency of exposure to medication by the infant can differ based on the dosage, frequency it is administered, and the time of day it is administered. Additionally, different drugs enter the infant's system via the gastrointestinal tract or breast milk. The impact on the health of a newborn isn't fully comprehended.

Due to the absence of research, some doctors may recommend stopping stimulant medications during a woman's pregnancy. This is a difficult decision for the mother, who must weigh over the counter adhd medication advantages of taking her medication as well as the risk to the foetus. As long as there is no more information, GPs should ask all pregnant patients about their experience with ADHD and if they are planning or taking to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue to take their ADHD medication safely while breastfeeding and during pregnancy. In response, a rising number of patients are choosing to continue their medication. They have concluded after consulting with their physicians, that the benefits of continuing their current medication outweigh possible risks.

Women with ADHD who plan to breastfeed should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their physician and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD recognize the signs and underlying disorder. They should also be informed about treatment options and build strategies for coping. This should be a multidisciplinary approach including obstetricians, GPs and psychiatry. The pregnancy counselling should consist of the discussion of a plan for management for both the mother and child, and monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.